Sabouret P - Search Results

1

NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View.

Angoulvant D, Sabouret P, Savage MP. Angoulvant D, et al. Among authors: sabouret p. Am J Cardiovasc Drugs. 2021 Sep;21(5):483-486. doi: 10.1007/s40256-021-00471-z. Epub 2021 Mar 6. Am J Cardiovasc Drugs. 2021. PMID: 33674980 Free PMC article.

2

Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions.

Perone F, Bernardi M, Redheuil A, Mafrica D, Conte E, Spadafora L, Ecarnot F, Tokgozoglu L, Santos-Gallego CG, Kaiser SE, Fogacci F, Sabouret A, Bhatt DL, Paneni F, Banach M, Santos R, Biondi Zoccai G, Ray KK, Sabouret P. Perone F, et al. Among authors: sabouret a, sabouret p. J Clin Med. 2023 Aug 26;12(17):5563. doi: 10.3390/jcm12175563. J Clin Med. 2023. PMID: 37685628 Free PMC article. Review.

3

Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?

Fogacci F, Di Micoli V, Sabouret P, Giovannini M, Cicero AFG. Fogacci F, et al. Among authors: sabouret p. J Clin Med. 2024 Jan 28;13(3):751. doi: 10.3390/jcm13030751. J Clin Med. 2024. PMID: 38337445 Free PMC article. Review.

4

Modulation and personalization of therapy after acute coronary syndromes: the road to precision.

Sabouret P, Biondi-Zoccai G, Banach M, Galli M. Sabouret P, et al. Eur Heart J. 2023 Jun 9;44(22):1965-1967. doi: 10.1093/eurheartj/ehad231. Eur Heart J. 2023. PMID: 37062814 No abstract available.

5

A consensus statement on lipid management after acute coronary syndrome.

Schiele F, Farnier M, Krempf M, Bruckert E, Ferrières J; French Group. Schiele F, et al. Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):532-543. doi: 10.1177/2048872616679791. Epub 2016 Nov 17. Eur Heart J Acute Cardiovasc Care. 2018. PMID: 27856518 Review.

6

FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodies.

Sabouret P, Angoulvant D, Pathak A. Sabouret P, et al. EuroIntervention. 2018 Jun 20;14(2):144-146. doi: 10.4244/EIJY18M04_1. EuroIntervention. 2018. PMID: 29701178 Free article. No abstract available.

7

Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction.

Schiele F, Lemesle G, Angoulvant D, Krempf M, Kownator S, Cheggour S, Belle L, Ferrières J; French Group. Schiele F, et al. Eur Heart J Acute Cardiovasc Care. 2020 Oct;9(7):788-801. doi: 10.1177/2048872619844444. Epub 2019 Apr 16. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 30990337 Review.

8

Lipoprotein(a), the rediscovered risk factor, or how to get "back to the future".

Sabouret P, Angoulvant D, Ray KK. Sabouret P, et al. Arch Cardiovasc Dis. 2020 Mar;113(3):147-151. doi: 10.1016/j.acvd.2020.03.008. Epub 2020 Mar 20. Arch Cardiovasc Dis. 2020. PMID: 32205042 Free article. No abstract available.

9

Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients.

Sabouret P, Savage MP, Fischman D, Costa F. Sabouret P, et al. Am J Cardiovasc Drugs. 2021 Jan;21(1):21-34. doi: 10.1007/s40256-020-00414-0. Am J Cardiovasc Drugs. 2021. PMID: 32394296 Review.

10

The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management.

Sabouret P, Galati G, Angoulvant D, Germanova O, Castelletti S, Pathak A, Metra M, Margonato A. Sabouret P, et al. Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):394-404. doi: 10.1093/ehjcvp/pvaa051. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32402065 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page